CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income		$ 336	$ 180	$ 3,697
Less: Income from discontinued operations, net of tax	[1]	0	0	(3,873)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities from continuing operations:
Depreciation, amortization and impairments		361	384	420
Contingent acquisition considerations fair value adjustments		(6)	16	21
Change in deferred income taxes		(108)	(84)	(29)
Stock-based compensation	[2]	110	118	69
Non-cash interest expense		9	10	14
Provision for bad debts and inventory charges		14	12	0
Loss on debt financing transactions		2	15	147
Gain on remeasurement of debt and other		0	0	(27)
Foreign currency transaction net losses, (gain) on sale of assets and other, net		(10)	21	(1)
Changes in assets and liabilities, net of effects of acquisitions:
Receivables		(148)	(68)	(35)
Inventories		2	(29)	(65)
Other assets and liabilities		(14)	(10)	(40)
Income taxes payable, net		25	(40)	(649)
Accounts payable and accrued liabilities		59	65	(74)
Net cash provided by (used in) operating activities from continuing operations		632	590	(425)
Net cash provided by operating activities from discontinued operations		0	0	44
Net cash provided by (used in) operating activities		632	590	(381)
Cash flows from investing activities:
Capital expenditures		294	242	216
Acquisitions of businesses and assets, net of cash acquired		(5)	(4)	(136)
Proceeds from settlement of cross-currency interest rate swaps		0	0	50
Proceeds from sale of investments and other, net		41	(2)	50
Net cash used in investing activities from continuing operations		(258)	(248)	(252)
Net cash (used in) provided by investing activities from discontinued operations(1)	[3]	0	(3)	6,368
Net cash (used in) provided by investing activities		(258)	(251)	6,116
Cash flows from financing activities:
Borrowings under revolving credit facilities		0	205	280
Repayments under revolving credit facilities		0	(205)	(280)
Proceeds from issuance of senior notes and term loans		0	550	2,200
Repayments of notes and term loans (including redemption premium)		0	(562)	(6,984)
Payments on long-term debt		(11)	(22)	(109)
Payments of debt issuance and deferred financing costs		(4)	(8)	(37)
Payments on license obligations		(34)	(31)	(35)
Payments of contingent acquisition considerations		(16)	(14)	(14)
Purchase of L&W common stock		(462)	(170)	(405)
Purchase of SciPlay’s Class A common stock		0	(23)	(37)
Acquisition of SciPlay noncontrolling interest		0	496	0
Net redemptions of common stock under stock-based compensation plans and other		(50)	(12)	(39)
Net cash used in financing activities from continuing operations		(577)	(788)	(5,460)
Net cash used in financing activities from discontinued operations		0	0	(3)
Net cash used in financing activities		(577)	(788)	(5,463)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(6)	3	(6)
(Decrease) increase in cash, cash equivalents and restricted cash		(209)	(446)	266
Cash, cash equivalents and restricted cash, beginning of period		521	967	701
Cash, cash equivalents and restricted cash, end of period		312	521	967
Less: Cash, cash equivalents and restricted cash of discontinued operations		0	0	0
Cash, cash equivalents and restricted cash of continuing operations, end of period		312	521	967
Supplemental cash flow information:
Cash paid for interest		286	306	351
Income taxes paid		164	147	692
Distributed earnings from equity investments		2	4	6
Cash paid for contingent acquisition considerations included in operating activities		$ 22	$ 17	$ 7

[1] (2) The year ended December 31, 2022 includes a pre-tax gain of $4,927 million on the sale of discontinued operations (see Note 1).

[2] (2) The years ended December 31, 2024, 2023 and 2022 include $43 million, $63 million and $24 million, respectively, classified as liability awards.

[3] (1) The year ended December 31, 2022 includes $6,409 million in gross cash proceeds from the sale of discontinued operations, net of cash, cash equivalents and restricted cash transferred.